Comparing BRCA1 mutations detected in our study of Brazilian ovarian cancer patients with those reported in breast cancer patients [11–13], it is interesting to observe that they are concordant with respect to the most recurrent variant, BRCA1 c.5266dupC, that also is one of the most commonly found in Latin American breast cancer patients [33]. The gene discussed is BRCA1; the disease is ovarian carcinoma.